Yonhap Infomax NewsDec 30
Korea Biomedicine Industry Association Chairman Lee Jeong-seok highlighted 2025 as a year of transition and restructuring for the bio industry, projecting significant growth and global competitiveness in the coming year through advances in AI drug development, biosimilars, and CDMO.
#YonhapInfomax #KoreaBiomedicineIndustryAssociation #Biopharmaceutical #AIDrugDevelopment #Biosimilars #CDMO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97657
Korea Biomedicine Industry Association Chief - 'A Year of Transition and Restructuring—Poised for Leap Forward in the New Year'

Korea Biomedicine Industry Association Chairman Lee Jeong-seok highlighted 2025 as a year of transition and restructuring for the bio industry, projecting significant growth and global competitiveness in the coming year through advances in AI drug development, biosimilars, and CDMO.

Yonhap Infomax
Yonhap Infomax NewsJun 18, 2025
SK Biopharmaceuticals Co. has signed an MOU with PhnyX Lab to jointly develop AI-powered solutions for automating drug discovery processes, aiming to boost global competitiveness.
#YonhapInfomax #SKBiopharmaceuticals #PhnyXLab #AIDrugDevelopment #Cheiron #MOU #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68036
SK Biopharmaceuticals Signs MOU with PhnyX Lab for AI-Driven Drug Development

SK Biopharmaceuticals Co. has signed an MOU with PhnyX Lab to jointly develop AI-powered solutions for automating drug discovery processes, aiming to boost global competitiveness.

Yonhap Infomax